Contact
Please use this form to send email to PR contact of this press release:
Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH
TO:
Please use this form to send email to PR contact of this press release:
Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH
TO: